p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The mechanisms by which p53 prevents development of cancer are much more complicated than previously thought. Under normal conditions, p53 is involved in cell-cycle arrest, Q1apoptosis, DNA repair, and inhibition of angiogenesis; it also promotes degradation of proteins through transcriptional regulation of certain target genes. Here we report the isolation of a novel transcriptional target of p53, designated p53RFP (p53-inducible RING-finger protein), whose product has E3 ubiquitin ligase activity. Its expression was negatively correlated to that of p21(WAF1) protein; p53RFP is likely to play a role in the regulation of this protein, probably through interaction with, and ubiquitination of, p21(WAF1). p53RFP appears to represent the second known example, the first being MDM2, of an E3 ubiquitin ligase as a p53 target. Our results further suggest that p53 might regulate the stability of p21(WAF1) through transcriptional regulation of p53RFP, and this feature may represent a novel mechanism for a p53-dependent cell-cycle checkpoint.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, PGM levels were unaffected by either Mdm2 or p53RFP, two ubiquitin ligases that are known to be regulated by p53 (refs. 35, 36; data not shown).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [35]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“GADD45 and a ribonucleotide reductase, p53R2, are involved in DNA repair, whereas p53AIP1, BAX, NOXA, KILLER/DR5, Fas, PIDD and are p53 targets that play significant roles in the p53-inducible apoptotic pathway (Vogelstein et al., 2000).”
BackgroundThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“Among the p53-target genes identified so far, p21WAF1, an inhibitor of cyclin-dependent kinase, is a well-known p53 mediator in arrest of the cell cycle at G1 (Harper et al., 1993).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 1×
“…in the ubiquitination pathway, as many of them have E3 ligase activity or function as essential cofactors of the E3 complex (Jackson et al., 2000; Joazeiro and Weissman, 2000). p53RFP might be the second known example of an E3 ubiquitin ligase as a p53 target (the first being MDM2, a negative…”
BackgroundOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172 · cited 1×
“…a p53-dependent manner as early as 12 h after infection (Figure 1a), but its induction revealed a 6 h delay, compared to that of p21WAF1, suggesting a distinct regulation by the modified p53 between the transcript and p21WAF1 as previously reported in another p53 target, p53AIP1 (Oda et al., 2000).”
ResultSelf-citationMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases
Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., & Reimann, J. D. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01834-1 · Cited by 634
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634
Zhang, Z.-X., Yang, L., Young, K. J., DuTemple, B., & Zhang, L. (2000) · Nature Medicine · doi:10.1038/77513 · Cited by 459 · cited 1×
“Parkin, another molecule with a RING-IBR-RING domain, functions as an E3ubiquitin ligase that binds an E2-ubiquitin-conjugating enzyme, UbcH8, to promote degradation of the synaptic vesicle-associated protein, CDCrel-1 (Zhang et al., 2000).”
Background
Research works printed but not linked: 1
- Hupp TR, Lane DP and Ball KL . (2000). Biochem. J., 352(Part 1), 1–17 · doi:10.1042/bj3520001 · Paper page
Cited by
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Mutual exclusivity analysis identifies oncogenic network modules
Ciriello, G., Cerami, E., Sander, C., & Schultz, N. (2012) · Genome Research · doi:10.1101/gr.125567.111 · Cited by 675
“It negatively regulates p21 (CDKN1A) which itself directly inhibits several cyclin-dependent kinases, including CCNE1 (Ng et al. 2003).”
BackgroundGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Self-citationRBR E3 ubiquitin ligases: new structures, new insights, new questions
Spratt, D. E., Walden, H., & Shaw, G. S. (2014) · Biochemical Journal · doi:10.1042/bj20140006 · Cited by 315
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
Lu, Z., & Hunter, T. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 224
Bauersachs, S., Ulbrich, S. E., Gross, K., Schmidt, S. E. M., Meyer, H. H. D., Wenigerkind, H., Vermehren, M., Sinowatz, F., Blum, H., & Wolf, E. (2006) · Reproduction · doi:10.1530/rep.1.00996 · Cited by 216
“The proteins encoded by these genes also have E3 ligase activity (Takeyama et al. 2003, Ng et al. 2003).”
BackgroundIsolation of p53‐target genes and their functional analysis
Nakamura, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03163.x · Cited by 169
Self-citationSmit, J. J., & Sixma, T. K. (2014) · EMBO Reports · doi:10.1002/embr.201338166 · Cited by 187
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Starostina, N. G., & Kipreos, E. T. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.004 · Cited by 147
The ring between ring fingers (RBR) protein family
Eisenhaber, B., Chumak, N., Eisenhaber, F., & Hauser, M.-T. (2007) · Genome Biology · doi:10.1186/gb-2007-8-3-209 · Cited by 119
“Auto-ubiquitination has been shown to inhibit E3 activity in members of the Ariadne, androgen receptor-associated protein 54 (ARA54), RNF144, dorfin, parkin and TRIAD3 subfamilies [10,16,49,56-62] (Additional data file 1).”
BackgroundParkin and relatives: the RBR family of ubiquitin ligases
Marín, I., Lucas‐Lledó, J. I., Gradilla, A., & Ferrús, A. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00226.2003 · Cited by 137
“Significant is also the finding (66) that a paralog of ARA54 (called IBRDC2 or p53RFP), regulated by p53, also encodes a protein with ubiquitin ligase activity and seems to negatively regulate the level of the cyclin/Cdk-interacting protein p21, suggesting an additional involvement of ARA54 subfamily genes in cell cyc…”
BackgroundRBR E3 ubiquitin ligases in tumorigenesis
Wang, P., Dai, X., Jiang, W., Li, Y., & Wei, W. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.002 · Cited by 111
The Role of the Transmembrane RING Finger Proteins in Cellular and Organelle Function
Nakamura, N. (2011) · Membranes · doi:10.3390/membranes1040354 · Cited by 89
“In the steady state, RNF144B is localized mainly in the cytosol [137,139,143], but it is translocated to mitochondria during apoptosis [143].”
BackgroundRNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage
Ho, S.-R., Mahanic, C. S., Lee, Y.-J., & Lin, W.-C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323107111 · Cited by 88
IBRDC2, an IBR‐type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation
Bénard, G., Neutzner, A., Peng, G., Wang, C., Livák, F., Youle, R. J., & Karbowski, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.39 · Cited by 96
“Our initial studies revealed that IBRDC2, an IBR-type RING-finger E3 Ub ligase that has already been implicated in p53-dependent apoptosis (Ng et al, 2003; Huang et al, 2006), accumulates on the mitochondria specifically upon apoptosis induction, in synchrony with Bax activation.”
BackgroundLee, J. Y., Yu, S. J., Park, Y. G., Kim, J., & Sohn, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01461-06 · Cited by 85
Differential control of TAp73 and ΔNp73 protein stability by the ring finger ubiquitin ligase PIR2
Sayan, B. S., Yang, A. L., Conforti, F., Tucci, P., Piro, M. C., Browne, G. J., Agostini, M., Bernardini, S., Knight, R. A., Mak, T. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911828107 · Cited by 81
“Although PIR2 has been previously described by two independent groups as a modulator of cell cycle arrest and apoptosis (27, 28), in our experimental model PIR2was not induced by p53 overexpression and did not induce cell cycle arrest or apoptosis when overexpressed.”
BackgroundWild-type p53 in cancer cells: When a guardian turns into a blackguard
Kim, E. L., Giese, A., & Deppert, W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.030 · Cited by 98
“[55] Ng CC, Arakawa H, Fukuda S, Kondoh H, Nakamura Y.”
BackgroundInfluentialMarteijn, J. A. F., van Emst, L., Erpelinck-Verschueren, C. A. J., Nikoloski, G., Menke, A. L., de Witte, T., Löwenberg, B., Jansen, J. H., & van der Reijden, B. A. (2005) · Blood · doi:10.1182/blood-2005-04-1450 · Cited by 62
“No interaction was observed between Triad1[1-119] and a panel of Ubcs28 tested, including CDC34, UbcH5, UbcH6, UbcH7, UbcH8, UbcH9, UbcH10, and UbcH13 (not shown).”
BackgroundZhao, J., Wang, C., Wang, J., Yang, X., Diao, N., Li, Q., Wang, W., Xian, L., Fang, Z., & Yu, L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.015 · Cited by 53
“For example, p53 destabilizes the p21 by inducing the expression of Ring-finger E3 ubiquitin ligase p53RFP [28].”
BackgroundGustafsson, N., Zhao, C., Gustafsson, J.-Α., & Dahlman‐Wright, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2674 · Cited by 53
Mapping the p53 transcriptome universe using p53 natural polymorphs
Wang, B., Niu, D., Lam, T. H., Xiao, Z., & Ren, E. C. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.132 · Cited by 52
Crosstalk of EDA-A2/XEDAR in the p53 Signaling Pathway
Tanikawa, C., Cui, R., Kumar, V., Nakamura, Y., & Matsuda, K. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0484 · Cited by 50
“Until now, we have reported several novel p53 target genes, such as p53R2, p53AIP1, p53RDL1, and PADI4 (4-11), and showed the critical mechanism by which p53 inhibits malignant transformation.”
BackgroundSelf-citationLee, M.-S., Seo, J., Choi, D. Y., Lee, E.-W., Ko, A., Ha, N., Yoon, J., Lee, H. W., Kim, K. P., & Song, J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.159 · Cited by 52
Sheng, C., Mendler, I.-H., Rieke, S., Snyder, P., Jentsch, M., Friedrich, D., Drossel, B., & Loewer, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.031 · Cited by 45
“Multiple cell cycle dependent degradation mechanisms exist for p21 (Figure S6A) (Ng et al., 2003; Starostina and Kipreos, 2012) with PCNA/CRL4-mediated degradation responsible for low p21 levels during S phase (Figure 3I) (Havens and Walter, 2009).”
BackgroundE6AP/UBE3A Ubiquitin Ligase Harbors Two E2∼ubiquitin Binding Sites
Ronchi, V. P., Klein, J. M., & Haas, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458059 · Cited by 47
“In humans, the Hect ligase family comprises 29 genes whose products occupy key regulatory roles within cells and share similar domain architectures comprised of a highly conserved 350-residue carboxyl-terminal Hect domain responsible for cognate E2 ubiquitin thioester binding and subsequent target protein conjugation;…”
BackgroundThe p53‐inducible E3 ubiquitin ligase p53RFP induces p53‐dependent apoptosis
Huang, J., Xu, L.-G., Liu, T., Zhai, Z., & Shu, H.-B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.09.105 · Cited by 37
Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx
Park, S., Min, J. Y., Chung, C., Hsieh, A., & Jung, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.019 · Cited by 33
RNF144B inhibits LPS-induced inflammatory responses via binding TBK1
Zhang, Z., Zhang, L., Wang, B., Zhu, X., Zhao, L., Chu, C., Guo, Q., Wei, R., Yin, X., Zhang, Y., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0819-055r · Cited by 33
PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63
Conforti, F., Yang, A. L., Piro, M. C., Mellone, M., Terrinoni, A., Candi, E., Tucci, P., Thomas, G. J., Knight, R. A., Melino, G., et al. (2012) · Oncogene · doi:10.1038/onc.2012.497 · Cited by 31
Kaushik, A., Parashar, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102279 · Cited by 33
Ho, S.-R., Lee, Y.-J., & Lin, W.-C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645499 · Cited by 28
“Both RNF144A and RNF144B are induced by p53 and promote cell apoptosis under various DNA damages (17, 18, 20, 21).”
BackgroundIdentification of p53–46F as a super p53 with an enhanced ability to induce p53‐dependent apoptosis
Nakamura, Y., Futamura, M., Kamino, H., Yoshida, K., Nakamura, Y., & Arakawa, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00214.x · Cited by 28
Self-citationValentin, J. (2005) · Annals of the ICRP · doi:10.1016/j.icrp.2005.11.005 · Cited by 20
Ariffin, J. K., Kapétanovic, R., Schaale, K., Gatica‐Andrades, M., Blumenthal, A., Schroder, K., & Sweet, M. J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0815-339r · Cited by 17
“Whatever the precise mechanism, several studies have shown that RNF144B promotes ubiquitination of proteins, to target them for degradation [15, 16, 18, 19].”
Backgroundp53 as the main traffic controller of the cell signaling network
Sebastian, S., Azzariti, A., Silvestris, N., Porcelli, L., Russo, A. D., & Paradiso, A. (2010) · Frontiers in bioscience · doi:10.2741/3669 · Cited by 16
“BTG2, TIS21 [113], DDIT4, REDD1 [114], FANCC, FAC”
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability
Abad, E., Sandoz, J., Romero, G., Zadra, I., Urgel-Solas, J., Borredat, P., Kourtis, S., Ortet, L., Martínez, C. M., Weghorn, D., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03045-4 · Cited by 14
“The observed peak in the human sample dataset corresponded with the p53 target sequence identified as p53BS1, which was already characterized to be present in the promoter region of RNF144B in a human glioblastoma cell line [33].”
BackgroundRubio, L. P., Vera-Sempere, F. J., López‐Guerrero, J. A., Padilla, J., & Moreno-Baylach, M. J. (2005) · PubMed · Cited by 12
Luo, L., Zhu, D., Huang, R., Xiong, L., Mehjabin, R., He, L., Liao, L., Li, Y., Zhu, Z., & Wang, Y. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.12.078 · Cited by 12
Rnf144b Alleviates the Inflammatory Responses and Cardiac Dysfunction in Sepsis
Guo, R., Wang, J., Tang, W. H., & Xiao, D. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14383 · Cited by 9
“regulate the stability of p21WAF1 or p63.(9,10) Rnf144b has also been identified as an E3 regulating Bax and apoptosis.”
BackgroundKaminski, H. J., Himuro, K., Alshaikh, J., Gong, B., Cheng, G., & Kusner, L. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00524 · Cited by 11
“Since these family members can form heterodimers, this suggests that these proteins may serve as a link between titin kinase and microtubule-dependent signal pathways in muscle (Ng et al., 2003).”
BackgroundInfluentialHaas, A. L. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch5b · Cited by 8
Haas, A. L. (2006) · Wiley eBooks · doi:10.1002/9783527620227.ch5 · Cited by 4
Zhang, H., Huang, N., Ma, X., & Liu, Y. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07397-9 · Cited by 4
RNF144A and RNF144B: Important molecules for health
Jiang, W. J., Liang, Y., Han, M., He, W., Chen, K., Deng, C., & Shen, Y. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1130 · Cited by 3
“Inhibition of the RNF144B expression by antisense oligonucleotides was reported to lead to accumulation of the p21WAF1 protein [74,75].”
RNF144A shapes the hierarchy of cytokine signaling to provide protective immunity against influenzaPreprint
Afzali, B., Kim, S., West, E. E., Nova‐Lamperti, E., Cheru, N. T., Nagashima, H., Yan, B., Freiwald, T., Merle, N. S., Chauss, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/782680 · Cited by 3
The regulatory network controlling DNA damage responses in Saccharomyces cerevisiae
Fu, Y. V. (2008) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 4
Wang, M., Zhang, Y., Gao, L., Zhang, H., Yang, Z., Liu, J., Shan, W., Zeng, L., Zhang, R., Liu, J., et al. (2023) · Medical Oncology · doi:10.1007/s12032-023-02157-9 · Cited by 1
“It has been found that diverse molecules or complexes are involved in the ubiquitination and degradation of p21, such as the Skp1/cullin/F-box (SCF) complexes [13], p53-inducible RING-finger protein (p53RFP) [14] and the anaphase-promoting complex/cyclosome (APC/C)Cdc20 [15].”
BackgroundValentin, J. (2005) · Annals of the ICRP · doi:10.1016/j.icrp.2005.11.003 · Cited by 1
Modeling p53 transcriptional regulation
Riley, T. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t31836rn
Cascade profiling of the ubiquitin-proteasome system in cancer
Rulina, A. (2015) · theses.fr (ABES) · doi:10.70675/e924c595z846cz44bfzbe0cz35dc656423d9
DNA Methylation in Rectal Cancer
Dbeis, R. (2018) · Figshare
Role of mitophagy in muscle growth and metabolism
Peker, N. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72691
Data from Glycolytic Enzymes Can Modulate Cellular Life Span
(2023) · doi:10.1158/0008-5472.c.6493056.v1
Self-citation
Metadata
- Authors
- Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y.
- Affiliations
- Institute of Medical Science, The University of Tokyo (JP)
- The University of Osaka (JP)
- Corresponding author
- Nakamura, Yusuke
- Venue
- Oncogene
- Published
- 2003-07-10
- Volume
- 22
- Issue
- 28
- Pages
- 4449-4458
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2012650432
- Cited by
- 54
- References
- 27
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 4 · 2020: 1 · 2019: 4 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- p53, p21, protein stability, E3 ubiquitin ligase, ubiquitination, transcription factor target genes, cell cycle checkpoints, tumor suppressor regulation, MDM2
- MeSH terms
- Amino Acid Sequence, Humans, Ligases, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Cyclins, Zinc Fingers, Ubiquitin-Protein Ligases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.